Figure 1 from Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy
Year: 2024
Type: other
Abstract: Tumor lineages of the cohort and analysis of OS by race. A, Total numbers of each tumor type broken down by study site. B, Percentage of the total made up by each study site for the top 10 most represented tumor types. C, Kaplan–Meier curve for OS of White patients (black line) and Black patients (red line) among molecularly-tested cohort. D, COXPH analyzing the effect of race on OS in individual tumor types. *, P < 0.05. E and F, Median survival among the Caris cohort (E) or 5-year survival among the SEER cohort (F) was plotted for male and female White and non-White patients in three different age groups (<50 years; 50 ≤ years < 65; and ≥65).
Authors: Elisabeth Heath, Gregory Dyson, Jennifer R. Ribeiro, Joanne Xiu, Kelsey Poorman, Hirva Mamdani, Mohammed N. Al-Hallak, Anthony F. Shields, Jailan A. Elayoubi, Ira S. Winer, Frank C. Cackowski, Gary A. Puckrein, Gilberto de Lima Lopes, Nathaniel Jones, Ralph J. Hauke, Samuel A. Kareff, Milan Radovich, George W. Sledge, David B. Spetzler, Gregory A. Vidal, John L. Marshall
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4403135871